AU2134595A - Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions - Google Patents

Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions

Info

Publication number
AU2134595A
AU2134595A AU21345/95A AU2134595A AU2134595A AU 2134595 A AU2134595 A AU 2134595A AU 21345/95 A AU21345/95 A AU 21345/95A AU 2134595 A AU2134595 A AU 2134595A AU 2134595 A AU2134595 A AU 2134595A
Authority
AU
Australia
Prior art keywords
prevention
treatment
pharmaceutical preparations
medicinal substances
endothelial dysfunctions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU21345/95A
Other versions
AU698359C (en
AU698359B2 (en
Inventor
Georg Kojda
Eike Albrecht Noack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Puren Pharma GmbH and Co KG
Original Assignee
Isis Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharma GmbH filed Critical Isis Pharma GmbH
Publication of AU2134595A publication Critical patent/AU2134595A/en
Application granted granted Critical
Publication of AU698359B2 publication Critical patent/AU698359B2/en
Publication of AU698359C publication Critical patent/AU698359C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AU21345/95A 1994-03-30 1995-03-28 Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions Ceased AU698359C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4410997A DE4410997A1 (en) 1994-03-30 1994-03-30 Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions
DE4410997 1994-03-30
PCT/DE1995/000421 WO1995026725A1 (en) 1994-03-30 1995-03-28 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction

Publications (3)

Publication Number Publication Date
AU2134595A true AU2134595A (en) 1995-10-23
AU698359B2 AU698359B2 (en) 1998-10-29
AU698359C AU698359C (en) 2000-10-19

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521571B2 (en) 2003-10-03 2009-04-21 Lacer Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521571B2 (en) 2003-10-03 2009-04-21 Lacer Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses
US7777058B2 (en) 2003-10-03 2010-08-17 Lacer S.A. Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
US8541607B2 (en) 2003-10-03 2013-09-24 Lacer, S.A. Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof

Also Published As

Publication number Publication date
SK121896A3 (en) 1998-10-07
IS4365A (en) 1996-09-25
LT4310B (en) 1998-03-25
LV11666A (en) 1997-02-20
CA2186783A1 (en) 1995-10-12
NO964102L (en) 1996-09-27
JPH09510979A (en) 1997-11-04
LV11666B (en) 1997-06-20
PL316528A1 (en) 1997-01-20
HU220165B (en) 2001-11-28
HU9602671D0 (en) 1996-11-28
AU698359B2 (en) 1998-10-29
FI963883A (en) 1996-09-27
HUT76676A (en) 1997-10-28
DE4410997A1 (en) 1995-10-26
CN1150387A (en) 1997-05-21
BG63073B1 (en) 2001-03-30
LT96148A (en) 1997-12-29
DE19580261D2 (en) 1997-05-28
BG100930A (en) 1997-07-31
MX9604434A (en) 1997-12-31
EE9600139A (en) 1997-04-15
FI963883A0 (en) 1996-09-27
CZ283696A3 (en) 1998-03-18
NO964102D0 (en) 1996-09-27
EP0752858A1 (en) 1997-01-15
WO1995026725A1 (en) 1995-10-12
SI9520047A (en) 1997-06-30

Similar Documents

Publication Publication Date Title
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
HU9602671D0 (en) Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
AU3171997A (en) Cosmetic and/or pharmaceutical preparations
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
AU4204697A (en) Tetrahydroisoquinoline derivatives and their pharmaceutical use
GB9808840D0 (en) Treatment of depression and pharmaceutical preparations therefor
AU7042796A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
AU5103196A (en) Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof
ZA9711129B (en) New analogues of camptothecin their medical application and the pharmaceutical substances that contain them
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
DE59410107D1 (en) CHINOXALINE AND MEDICINAL PRODUCTS THEREOF
IL117078A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
AU6126398A (en) Alcoholic treatment and homeopathic pharmaceutical product
AU698359C (en) Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions
PL312563A1 (en) Pharmaceutical immunomodulating and treatment aiding preparation
ZA951789B (en) Pharmaceutical materials and methods of administration
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
EP0784972A3 (en) Cosmetic and/or pharmaceutical emulsions
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 19990211

MK14 Patent ceased section 143(a) (annual fees not paid) or expired